# Pierfrancesco Tassone

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pierfrancesco-tassone/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,759 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 82 |
| i10-index | 261 |
| Last Known Institution | Magna Graecia University |
| OpenAlex ID | https://openalex.org/A5077467836 |
| ORCID iD | https://orcid.org/0000-0002-8298-6787 |
| Works | 624 |

## Researcher papers

- [Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/neratinib-after-trastuzumab-based-adjuvant-therapy-in-her2-positive-breast/)
- [Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial](https://scholariq.org/papers/tepotinib-plus-gefitinib-in-patients-with-egfr-mutant-non-small-cell-lung-cancer/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

## Researcher university

- [Magna Graecia University](https://scholariq.org/institutions/magna-graecia-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.